Arzu Onar‐Thomas

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

1.8Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4731

Top 12%

1.8DataRank

Top 12%68 citations

Giles Robinson, Arzu Onar‐Thomas, Brent A. Orr, Pascal D. Johann, Gang Wu +28 more

Papers

Driven by 22 papers — median percentile 88. Top paper: “Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study”.

Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study

Neuro-Oncology(2021)10.1093/neuonc/noab030

N/A

2.4DataRank · unranked

98 citations

Zoltán Patay, Paul Klimo, Jie Huang, Rahul Kumar, Frederick A. Boop +9 more

A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study

Neuro-Oncology(2020)10.1093/neuonc/noaa016

N/A

2.4DataRank · unranked

90 citations

Jack M. Su, Arzu Onar‐Thomas, Catherine A. Billups, Xiao‐Nan Li, Tina Young Poussaint +13 more

Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4731

Top 12%

1.8DataRank

Top 12%68 citations

Giles Robinson, Arzu Onar‐Thomas, Brent A. Orr, Pascal D. Johann, Gang Wu +28 more

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

Neuro-Oncology(2021)10.1093/neuonc/noab047

N/A

0.761DataRank · unranked

159 citations

Arzu Onar‐Thomas, Tina Young Poussaint, Shengjie Wu, Azra H. Ligon, Neal I. Lindeman +18 more

Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)

Neuro-Oncology(2023)10.1093/neuonc/noad141

N/A

0.626DataRank · unranked

64 citations

Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury +14 more

Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy

Molecular Cancer(2024)10.1186/s12943-024-02027-6

N/A

0.442DataRank · unranked

18 citations

Chen He, Jared Andrews, Aditi Bagchi, Roketa Sloan-Henry, Brandon Bianski +29 more

Phase II study of alisertib as a single agent in recurrent or progressive atypical teratoid rhabdoid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10542

N/A

0DataRank · unranked

9 citations

Olivia Campagne, Giles Robinson, Arzu Onar‐Thomas, Brent A. Orr, Catherine A. Billups +12 more

Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)

Neuro-Oncology(2021)10.1093/neuonc/noab293

N/A

0DataRank · unranked

34 citations

Lindsay Kilburn, J. Russell Geyer, Mehmet Koçak, Jie Huang, Kyle Smith +13 more

Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab179

N/A

0DataRank · unranked

20 citations

Alberto Broniscer, Jason Chiang, Olivia Campagne, Jie Huang, Brent A. Orr +11 more

Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor

Neuro-Oncology(2022)10.1093/neuonc/noac151

N/A

0DataRank · unranked

30 citations

Olivia Campagne, Catherine A. Billups, Brent A. Orr, Arzu Onar‐Thomas, Ruth G. Tatevossian +23 more

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0598

N/A

0DataRank · unranked

12 citations

Barbara Jonchère, Jingjing Liu, Kyle Smith, Olivia Campagne, Ke Xu +10 more

Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium

American Journal of Neuroradiology(2020)10.3174/ajnr.a6499

N/A

0DataRank · unranked

27 citations

Douglas L. Brown, Catherine A. Billups, Zoltán Patay, Gilbert Vézina, Mark S. Shiroishi +7 more

ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma

Neuro-Oncology(2023)10.1093/neuonc/noad064

N/A

0DataRank · unranked

22 citations

Teneema Kuriakose, Brandon Bianski, Nathaniel Twarog, Evan Savage, Ke Xu +19 more

Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30600

N/A

0DataRank · unranked

12 citations

Arzu Onar‐Thomas, Jason Fangusaro, Nicholas G. Gottardo, Kenneth J. Cohen, Amy Smith +4 more

Population pharmacokinetics of methotrexate and 7-hydroxymethotrexate and delayed excretion in infants and young children with brain tumors

European Journal of Pharmaceutical Sciences(2023)10.1016/j.ejps.2023.106669

N/A

0DataRank · unranked

8 citations

Jie Huang, Tong Lin, Wilburn E. Reddick, Nicholas S. Selvo, Arzu Onar‐Thomas +5 more

Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single‐institution study with molecular correlation

Pediatric Blood & Cancer(2024)10.1002/pbc.31208

N/A

0DataRank · unranked

6 citations

Jie Huang, Jason R. Myers, Roya Mostafavi, Brent A. Orr, Sandeep Kumar Dhanda +15 more

Imaging mediation analysis for longitudinal outcomes: a case study of childhood brain tumor survivorship

Statistics and Its Interface(2024)10.4310/23-sii815

N/A

0DataRank · unranked

0 citations

Xiaoqing Wang, Zhou Chen, Heather M. Conklin, Arzu Onar‐Thomas, Amar Gajjar +3 more

A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4

Neuro-Oncology(2025)10.1093/neuonc/noaf065

N/A

0DataRank · unranked

13 citations

Arzu Onar‐Thomas, Tina Young Poussaint, Shelly Lensing, Azra H. Ligon, Neal Lindeman +14 more

FOXR2 activation is not exclusive of CNS neuroblastoma

Neuro-Oncology(2025)10.1093/neuonc/noaf076

N/A

0DataRank · unranked

2 citations

Emily Hanzlik, Maria Cardenas, Mohammad K. Eldomery, Soniya Pinto, Christopher L. Tinkle +15 more

Neurocognitive outcomes following 30.6-Gy whole-ventricular radiotherapy with 54-Gy total dose focal tumor bed boost for CNS non-germinomatous germ cell tumors: A Children’s Oncology Group study (ACNS1123).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.10036

N/A

0DataRank · unranked

0 citations

Yu Wang, Christine L. Trask, Arzu Onar‐Thomas, Jason Fangusaro, Ute Bartels +3 more

Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-019-04026-7

N/A

0DataRank · unranked

0 citations

Olivia Campagne, Jie Huang, Arzu Onar‐Thomas, Alberto Broniscer, Amar Gajjar +2 more

Response to: Bayesian reappraisal of ACNS0332 and ACNS0334 strengthens subgroup treatment effects in high-risk pediatric group 3 medulloblastoma

Neuro-Oncology(2025)10.1093/neuonc/noaf212

N/A

0DataRank · unranked

0 citations

Sarah Leary, Arzu Onar‐Thomas, Yimei Li, Guolian Kang

Arzu Onar‐Thomas

Indexed papers

Top data-sharing exemplar

Papers